Predictors of HCV Response to Treatment with Pegylated Interferon and Ribavirin in Sharkia Governorate
Background and study aim: The current standard of care (SOC) for chronic hepatitis C (CHC) in Egypt is pegylated interferon and ribavirin (PEG-INF/RBV) for 48 weeks, which is expensive, can be difficult to tolerate and with high failure rate. Additional information about predicting sustained virolog...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department
2012-03-01
|
| Series: | Afro-Egyptian Journal of Infectious and Endemic Diseases |
| Assuntos: | |
| Acceso en liña: | https://aeji.journals.ekb.eg/article_15415_42bdc9b8194658d83a9006087abfc96b.pdf |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|